Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female participants aged 18 to 65 years with history of seasonal allergic rhinitis~* Participants able to understand and willing to sign the informed consent form~Exclusion Criteria:~* Anotomical deviations of the nasal septum that significantly impair ventilation or airflow~* Pregnant or nursing women~* Positive serology for infectious disease (Hepatitis B or C, HIV) at screening~* Parallel participation in another current investigational study, participation in a study within less than 30 days prior to study entry, or previous participation in this same study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- SPARC Placebo (Type: PLACEBO_COMPARATOR): None
- SPARC1310 I (Type: EXPERIMENTAL): None
- SPARC1310 II (Type: EXPERIMENTAL): None
- SPARC1310 III (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).